Free Sample of Silenor
Silenor Savings Program

Site Map

  • Home
  • What are your sleep issues?
    • Do You Have Difficulty Staying Asleep?
    • Do You Have Concerns About Addiction?
    • Do You Experience Early-Morning Awakenings?
  • Health Risks of Insomnia
    • How Does Insomnia Increase the Risk of Accidents and Injuries?
  • Silenor Product Profile
    • Is Silenor a Controlled Substance?
    • Silenor: Safety and Tolerability Profile
  • How Silenor is Believed to Work
  • Talking to Your Healthcare Provider
  • Resources
    • Silenor Prescription Savings Program
    • Sleep-Saver™ Program – Extended
    • Registration
  • Prescribing Information
  • Patient Medication Guide
  • Important Safety Information
  • Registration
  • Privacy Policy
  • Terms of Use
  • Contact Us
  • Send to a Friend
  • Site Map
  • www.somaxon.com
  • Visit US Healthcare Provider Site

Silenor is a prescription sleep medicine that is used to treat people with insomnia who have trouble staying asleep.

IMPORTANT SAFETY INFORMATION

Call your doctor if your insomnia worsens or is not better within 7 to 10 days. This may mean that there is another condition causing your sleep problem.

Be sure that you are able to devote 7 to 8 hours to sleep before being active again. Silenor should be taken within 30 minutes of bedtime. Do not take with alcohol or with other medicines that can make you sleepy. If you are on a monoamine oxidase inhibitor (MAOI) or have taken a MAOI within the past two weeks, you should not take Silenor. You should not take Silenor if you have an eye problem called narrow angle glaucoma that is not being treated, if you have severe urinary retention, or if you are allergic to any of the ingredients in Silenor. You should not drive or operate machinery at night after taking Silenor. Until you know how you will react to Silenor, you should be careful in performing such activities during the day following taking Silenor. Before you take Silenor, tell your doctor if you have a history of depression, mental illness or suicidal thoughts. You should call your doctor right away if after taking Silenor you walk, drive, eat or engage in other activities while asleep. Drowsiness is the most common adverse event observed in clinical trials. For more information, please see the complete Prescribing Information, including the Medication Guide.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

  • Prescribing Information
  • |
  • Patient Medication Guide
  • |
  • Important Safety Information
  • |
  • Registration
  • |
  • Privacy Policy
  • |
  • Terms of Use
  • |
  • Contact Us
  • |
  • Site Map
  • |
  • www.somaxon.com

©2012 Somaxon Pharmaceuticals, Inc. All rights reserved. Silenor and Somaxon are registered trademarks of Somaxon Pharmaceuticals, Inc.

The product information provided in this site is intended only for residents of the United States. The health information contained herein is provided for educational purposes only and is not intended to replace discussions with a healthcare provider. All decisions regarding patient care must be made with a healthcare provider, considering the unique characteristics of the patient.

SIL-0069.P7A

Somaxon Pharmaceuticals
Silenor doxepin
    • A
    • A
    • A
  • Send to a Friend
  • Send to a Friend
  • Print This Page
  • Print this Page
  • Important Safety Information
  • Visit US Healthcare Provider Site
  • Resources
    • Silenor Prescription Savings Program
    • Sleep-Saver™ Program
    • Registration
  • Talking to Your Healthcare Provider
  • How Silenor is Believed to Work
  • Silenor Product Profile
    • Is Silenor a Controlled Substance?
    • Silenor: Safety and Tolerability Profile
  • Health Risks of Insomnia
    • How Does Insomnia Increase the Risk of Accidents and Injuries?
  • What are your sleep issues?
    • Do You Have Difficulty Staying Asleep?
    • Do You Have Concerns About Becoming Addicted to Your Sleep Medication?
    • Do You Experience Early-Morning Awakenings?
Silenor doxepin

Close Window X

The information contained in this section of Silenor.com is technical in nature and was specifically created for healthcare providers. If you are not a healthcare provider and would like to return to the consumer section of the site, please click the return button below.

Yes, I am a Healthcare Provider and would like to continue.

Continue
Return
Silenor doxepin

Close Window X

You are about to leave the Silenor (doxepin) website and enter a website operated by an independent third party. The links to third-party websites contained in Silenor.com are provided solely for your convenience. Somaxon Pharmaceuticals, Inc. does not control the opinions, claims, or comments contained in any third-party website linked to Silenor.com, and your activities at those websites will be governed by the policies and practices of those third parties.

Click "Continue" to proceed to this third-party website or "Return" to stay at Silenor.com.

Continue
Return